Cargando…
A novel tumor suppressor function of Kindlin-3 in solid cancer
Kindlin-3 (FERMT-3) is known to be central in hemostasis and thrombosis control and its deficiency disrupts platelet aggregation and causes Leukocyte Adhesion Deficiency disease. Here we report that Kindlin-3 has a tumor suppressive role in solid cancer. Our present genetic and functional data show...
Autores principales: | Djaafri, Ibtissem, Khayati, Farah, Menashi, Suzanne, Tost, Jorg, Podgorniak, Marie-Pierre, Sadoux, Aurelie, Daunay, Antoine, Teixeira, Luis, Soulier, Jean, Idbaih, Ahmed, Setterblad, Niclas, Fauvel, Françoise, Calvo, Fabien, Janin, Anne, Lebbé, Celeste, Mourah, Samia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253411/ https://www.ncbi.nlm.nih.gov/pubmed/25344860 |
Ejemplares similares
-
EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF
por: Khayati, Farah, et al.
Publicado: (2015) -
EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2
por: Bougatef, Faten, et al.
Publicado: (2010) -
EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression
por: Lescaille, Géraldine, et al.
Publicado: (2012) -
A Reliable Method for the Selection of Exploitable Melanoma Archival Paraffin Embedded Tissues for Transcript Biomarker Profiling
por: Lebbe, Celeste, et al.
Publicado: (2012) -
Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor
por: Louveau, Baptiste, et al.
Publicado: (2017)